125 related articles for article (PubMed ID: 202718)
1. Complement-dependent cytotoxic antitumor antibody. I. Immunoglobulin class determined by interaction with protein A or concanavalin A.
Langone JJ; Boyle MD; Borsos T
J Natl Cancer Inst; 1978 Feb; 60(2):411-8. PubMed ID: 202718
[No Abstract] [Full Text] [Related]
2. Augmentation of tumor-specific immunogenicity by concanavalin A in the Morris hepatoma 5123.
Enker WE; Craft K; Wissler RW
J Surg Res; 1974 Jan; 16(1):66-8. PubMed ID: 4131863
[No Abstract] [Full Text] [Related]
3. Effect of concanavalin A on the killing of tumor cells by antibody and complement.
Boyle MD; Langone JJ; Ohanian SH; Borsos T
J Immunol; 1977 May; 118(5):1626-30. PubMed ID: 192797
[TBL] [Abstract][Full Text] [Related]
4. Lysis of tumor cells by antibody and complement. 1. Lack of correlation between antigen content and lytic susceptibility.
Ohanian SH; Borsos T; Rapp HJ
J Natl Cancer Inst; 1973 May; 50(5):1313-20. PubMed ID: 4351395
[No Abstract] [Full Text] [Related]
5. In vitro effects of antitumor antibody--chemotactic factor complexes.
Obrist R; Sandberg AL
Clin Immunol Immunopathol; 1982 Oct; 25(1):91-102. PubMed ID: 6295673
[No Abstract] [Full Text] [Related]
6. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
Schlager SI; Ohanian SH; Borsos T
Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
[TBL] [Abstract][Full Text] [Related]
7. Effect of metabolic inhibitors on killing of tumor cells by antibody and complement.
Segerling M; Ohanian SH; Borsos T
J Natl Cancer Inst; 1974 Nov; 53(5):1411-3. PubMed ID: 4372384
[No Abstract] [Full Text] [Related]
8. [Bleomycin-induced tumor cell lysis caused by antibodies and complement].
Bier J; Ohanian SH
Dtsch Zahnarztl Z; 1980 Jan; 35(1):102-4. PubMed ID: 6157512
[TBL] [Abstract][Full Text] [Related]
9. Effect of protease treatment on the sensitivity of tumor cells to antibody-GPC killing.
Boyle MD; Ohanian SH; Boros T
Clin Immunol Immunopathol; 1978 May; 10(1):84-94. PubMed ID: 207478
[No Abstract] [Full Text] [Related]
10. Resistance of guinea-pig hepatoma cells to complement-mediated lysis induced by ascites fluid or serum from tumor-bearing animals.
Abe S; Berczi I; Sehon AH
Int J Cancer; 1977 Oct; 20(4):595-606. PubMed ID: 199549
[TBL] [Abstract][Full Text] [Related]
11. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
Boyle MD; Ohanian SH; Borsos T
J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical detection of tumor-specific and embryonic antigens of diethylnitrosamine-induced guinea pig tumors.
Borsos T; Richardson AK; Ohanian SH; Leonard EJ
J Natl Cancer Inst; 1973 Dec; 51(6):1955-60. PubMed ID: 4128823
[No Abstract] [Full Text] [Related]
13. Immunotherapy with tumor cells and BCG in the guinea pig, studied by immunological in vivo and in vitro experiments.
Rella W; Chaput B
Oncology; 1978; 35(3):136-42. PubMed ID: 209379
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to and escape from complement-mediated lysis of guinea-pig hepatoma line-10.
Abe S; Berczi I; Sehon AH
Int J Cancer; 1977 Jul; 20(1):137-45. PubMed ID: 198379
[TBL] [Abstract][Full Text] [Related]
15. Persistence of immunoglobulin and complement components C4 and C3 bound to guinea pig tumor cells.
Segerling M; Ohanian SH; Borsos T
J Natl Cancer Inst; 1976 Jul; 57(1):145-50. PubMed ID: 187759
[TBL] [Abstract][Full Text] [Related]
16. Effect of concanavalin A on the functional activity of hemolytic antibody.
Langone JJ; Boyle MD; Borsos T
Immunol Commun; 1977; 6(3):283-96. PubMed ID: 885582
[TBL] [Abstract][Full Text] [Related]
17. Complement-dependent cytotoxicity against hepatoma cells mediated by IgM antibodies in serum from tumor-bearing rats.
Lando P; Blomberg F; Raftell M; Berzins K; Perlmann P
Scand J Immunol; 1977; 6(11):1081-92. PubMed ID: 202015
[TBL] [Abstract][Full Text] [Related]
18. Humoral immune responses to tumor-specific antigens in strain-2 guinea pigs.
Smith HG; Leonard EJ
J Natl Cancer Inst; 1974 Jul; 53(1):187-94. PubMed ID: 4366195
[No Abstract] [Full Text] [Related]
19. Complement-dependent cytotoxic antitumor antibody. II. Quantitative determination of cell-bound immunoglobulin M1.
Boyle MD; Langone JJ
J Natl Cancer Inst; 1979 Jun; 62(6):1537-44. PubMed ID: 286124
[TBL] [Abstract][Full Text] [Related]
20. Enhancing effect by metabolic inhibitors on the killing of tumor cells by antibody and complement.
Segerling M; Ohanian SH; Borsos T
Cancer Res; 1975 Nov; 35(11 Pt 1):3195-203. PubMed ID: 52404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
